STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Ainos, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Taiwan Carbon Nano Technology Corporation (TCNT) reports it directly holds 1,037,206 shares of Ainos, Inc. common stock, representing 21.79% of the outstanding shares after the issuer's one-for-five reverse stock split. TCNT acquired a larger position when the issuer issued 5,500,000 shares under a license agreement in exchange for patent rights and subsequently adjusted for the reverse split.

TCNT sold 62,794 shares between the end of June and early October and states those sales were for general operating purposes. TCNT is subject to a voting agreement that requires it to vote its shares as directed by Ainos KY while Ainos KY holds at least 10% of the issuer's shares. No litigation or other arrangements are disclosed.

Positive

  • Significant economic stake: TCNT beneficially owns 1,037,206 shares, representing 21.79% of outstanding stock
  • Strategic IP transaction: Issuance of 5,500,000 shares was in exchange for a license to patented technology related to gas sensors and medical devices

Negative

  • Share sales: TCNT sold 62,794 shares from late June through early October for general operating purposes
  • Voting control constrained: TCNT must vote its shares as directed by Ainos KY, limiting independent voting influence despite economic ownership

Insights

Major shareholder holds >20% and is bound by a voting agreement.

The filing shows TCNT beneficially owns 1,037,206 shares, or 21.79%, giving it significant influence on shareholder votes. That influence is constrained by a voting agreement under which TCNT must vote as directed by Ainos KY while Ainos KY retains at least 10% ownership.

This arrangement concentrates voting control with Ainos KY despite TCNT's large economic stake; monitor any changes in Ainos KY's stake, since the voting agreement terminates if its ownership falls below 10%.

Transaction history shows issuance for intellectual property and subsequent modest share sales.

The reporting details an issuance of 5,500,000 shares to TCNT under a license for patented technology and a subsequent one-for-five reverse split that adjusted TCNT's holding to 1,037,206 shares. From the post-split period, TCNT sold 62,794 shares for general operating purposes.

Investors should note the share issuance was consideration for licensed patents, and the recent sales reduced the holding slightly; any further material disposals or transfers would change the disclosed 21.79% ownership level.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The number of securities in Row 7 includes, after giving effect to the one-for-five reverse stock split of the Issuer's common stock effected on June 30, 2025 (the "June 2025 Reverse Split"),1,037,206 shares of common stock, $0.01 par value, of Ainos, Inc., a Texas corporation (the "Issuer"), owned directly by Taiwan Carbon Nano Technology Corporation ("TCNT"), which are subject to a voting agreement between TCNT and Ainos Inc., a Cayman Islands corporation ("Ainos KY"). The percentage in Row 13 is based on 4,759,021 shares of Common Stock outstanding as of September 5, 2025 as set forth in the prospectus supplement of the Issuer filed with the SEC on September 5, 2025, 2025. Except as set forth below, there are no changes to the information set forth in the Statement. Items 2, 3, 4, 5 and 6 of the Statement are hereby amended as follows:


SCHEDULE 13D


Taiwan Carbon Nano Technology Corporation
Signature:/s/ Chun-Hsien Tsai
Name/Title:Chairman, Chief Executive Officer
Date:10/09/2025

FAQ

How many Ainos (AIMD) shares does TCNT beneficially own?

TCNT beneficially owns 1,037,206 shares, representing 21.79% of outstanding common stock.

Why did TCNT receive shares from Ainos?

TCNT received 5,500,000 shares as consideration for granting an exclusive, perpetual license to certain patents related to gas sensors and medical devices.

Did TCNT sell any Ainos shares recently?

Yes. TCNT sold a total of 62,794 shares between the post-reverse-split period and early October for general operating purposes.

Does TCNT control how it votes its Ainos shares?

No. Under a voting agreement, TCNT agreed to vote its Ainos shares as directed by Ainos KY while Ainos KY holds at least 10% of the issuer's shares.

How did the reverse stock split affect TCNT's reported holdings?

A one-for-five reverse split reduced the number of issued shares; the filing reports TCNT's adjusted holding as 1,037,206 shares after the split.
Ainos Inc

NASDAQ:AIMD

AIMD Rankings

AIMD Latest News

AIMD Latest SEC Filings

AIMD Stock Data

9.24M
1.94M
56.73%
0.13%
2.59%
Medical Devices
Pharmaceutical Preparations
Link
United States
SAN DIEGO